Billionaires Invest in Lab-Grown Organ Technology
A group of billionaires worldwide is investing in a biotechnology company focused on producing genetically modified monkey organs, paving the way for the potential creation of human organs in laboratories. This initiative could revolutionize the future of organ transplantation.